2026-01-02 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG) based on the provided data:

**1) Return Rate Comparison with S&P 500 (VOO)**

*   **PG Overview:** Procter & Gamble Co. is a multinational consumer goods corporation that manufactures and markets a wide range of branded products.
*   **PG Cumulative Return:** 20.02%
*   **VOO (S&P 500) Cumulative Return:** 91.40%
*   **Divergence:** -85.1 (Relative Divergence: 3.8)

**Analysis:** PG has significantly underperformed the S&P 500 over the period examined. The negative divergence of -85.1 shows a considerable gap in returns.  The Relative Divergence of 3.8 indicates that the current divergence is near the lowest end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha   | Beta  | Cap(B) |
|------------|---------|--------|---------|-------|--------|
| 2016-2018  | 4.0%    | 99.6%  | 1.0%    | 0.5   | 215.1  |
| 2017-2019  | 23.0%   | 99.6%  | 5.0%    | 0.5   | 292.3  |
| 2018-2020  | 26.0%   | 98.6%  | 5.0%    | 0.7   | 325.7  |
| 2019-2021  | 39.0%   | 82.5%  | -5.0%   | 0.7   | 382.9  |
| 2020-2022  | 11.0%   | 81.7%  | 13.0%   | 0.6   | 354.7  |
| 2021-2023  | 24.0%   | 68.5%  | 23.0%   | 0.4   | 343.0  |
| 2022-2024  | 7.0%    | 67.1%  | -12.0%  | 0.4   | 392.4  |
| 2023-2025  | -19.0%  | 75.9%  | -81.0%  | 0.2   | 335.4  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** The CAGR shows fluctuating growth rates, with a recent decline to -19.0% in the 2023-2025 period.
*   **MDD (Maximum Drawdown):** The MDD has generally decreased over time, suggesting less volatility.
*   **Alpha:** Alpha, which represents the excess return compared to the benchmark, has been highly variable.  The recent -81% alpha for 2023-2025 is concerning, indicating significant underperformance.
*   **Beta:** Beta is consistently below 1, indicating that PG is less volatile than the overall market. It has trended downward in recent years.
*   **Cap(B) (Market Cap in Billions):** Market Cap has fluctuated, showing growth in some periods and decline in others.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 143.31
*   **Previous Close:** 144.05
*   **Change:** -0.51
*   **5-day SMA:** 144.23
*   **20-day SMA:** 143.60
*   **60-day SMA:** 147.15

**Analysis:** The stock price is currently below its 5-day and 60-day moving averages, but above its 20-day moving average. This suggests a potential short-term downward trend, but further analysis is needed to confirm. The recent slight negative change is not drastically large, but should still be noted.

**3) RSI, PPO, and Expected Return**

*   **MRI (Market Risk Indicator):** 0.9 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 60.52
*   **PPO (Percentage Price Oscillator):** 0.13
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 1.7 (+): 단기상승 (short-term increase)
*   **Expected Return (%):** 0.0%

**Analysis:**

*   The high MRI of 0.9 suggests that the stock is considered a relatively safe investment according to this indicator.
*   An RSI of 60.52 indicates slightly bullish momentum, but not overbought conditions.
*   A PPO of 0.13 indicates that the shorter-term moving average is slightly above the longer-term moving average, also suggesting bullish momentum.
*   The "Hybrid Signal" recommends buying the stock, reinforcing the MRI's safety rating.
*   The 20-day divergence change suggests a short-term upward trend.
*   The 0.0% Expected Return is concerning and suggests that analysts do not see significant growth potential at the current price.

**4) Recent News & Significant Events**

*   **Positive Mentions:** Jim Cramer (CNBC, Yahoo Finance) is generally positive on PG, suggesting patience will pay off and highlighting it as a favorite portfolio stock. Forbes suggests buying PG over Colgate-Palmolive
*   **Negative News:**  Investopedia reported on a 2-year low for PG's stock price.
*   **Institutional Activity:** MarketBeat reports Ninety One North America Inc. sold shares.
*   **Year-End Trading:** ts2.tech discusses investor knowledge for year-end trading.

**Analysis:** The news is a mixed bag. Positive commentary from Jim Cramer provides some optimism, while reports of a 2-year low and institutional selling raise concerns. The news suggests a degree of investor uncertainty.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~1.92)
*   **Target Price:** Average $168.95, High $186.00, Low $148.00

**Analysis:**  The analyst consensus is "Buy," indicating positive sentiment. The average target price of $168.95 suggests a potential upside from the current price of $143.31.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출         |
|------------|------|--------------|
| 2025-10-24 | 2    | 22.39 B$     |
| 2025-04-24 | 1.58 | 19.78 B$     |
| 2025-01-22 | 1.94 | 21.88 B$     |
| 2024-10-18 | 1.65 | 21.74 B$     |
| 2025-10-24 | 1.65 | 21.74 B$     |

**Analysis:**

*   **EPS (Earnings Per Share):** EPS has been variable.
*   **Revenue:** Revenue has also fluctuated, with a high of $22.39B in the most recent quarter.

Overall, the recent earnings data shows mixed results with fluctuating EPS and Revenue

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $22.39B    | 51.37%        |
| 2025-06-30   | $20.89B    | 49.11%        |
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-09-30   | $53.27B    | 8.92%  |
| 2025-06-30   | $52.01B    | 6.95%  |
| 2025-03-31   | $52.27B    | 7.21%  |
| 2024-12-31   | $51.17B    | 9.05%  |
| 2024-09-30   | $51.84B    | 7.64%  |

**Analysis:**

*   **Revenue:** Revenue shows fluctuations, but the most recent quarter shows the highest revenue in the set.
*   **Profit Margin:**  Profit margins are consistently high, indicating strong operational efficiency.
*   **Equity:** Equity is relatively stable.
*   **ROE (Return on Equity):** ROE is also variable, fluctuating between 6.95% and 9.05%.

The financial data highlights PG's consistent profitability and relatively stable financial position, however, some metrics fluctuate and do not consistently show growth.

**7) Comprehensive Analysis (Summary)**

Procter & Gamble (PG) is a large, established consumer goods company with a strong brand portfolio.

*   **Underperformance:** PG has significantly underperformed the S&P 500 over the period examined.
*   **Volatility:** PG is less volatile than the overall market (Beta < 1).
*   **Mixed Signals:** Technical indicators show mixed signals (RSI, PPO), recent news is mixed, and there is a lack of significant expected return.
*   **Financial Stability:** PG maintains high profit margins and stable equity.
*   **Analyst Sentiment:** Analysts generally have a "Buy" rating with a target price suggesting some potential upside, however, institutional investor sentiment seems mixed.
*   **Caution Advised:** The large fluctuation of alpha during periods such as 2023-2025 indicates that PG may not be a good investment for everyone.

**Overall Recommendation:** Based on this data, a cautious approach to investing in PG is warranted. While the company is financially sound and has a strong market position, the underperformance relative to the S&P 500 and the lack of significant expected return are concerning. The mixed technical and news signals further add to the uncertainty. Investors should carefully weigh these factors and consider their individual risk tolerance and investment goals before investing in PG.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.